The Female Health Company Schedules Third Quarter Conference Call for August 12,...

The Female Health Company Schedules Third Quarter Conference Call for August
12, 2008

CHICAGO, Aug. 5 /PRNewswire-FirstCall/ -- The Female Health Company
(Amex: FHC) today announced that it will host an investor conference call to
discuss its operating results for the third quarter of FY2008 at 11:00 a.m.
Eastern Time (EDT) on Tuesday, August 12, 2008. The Company plans to report
its third quarter FY2008 operating results earlier the same day.
Shareholders and other interested parties may participate in the
conference call by dialing 800-860-2442 (international participants dial
412-858-4600) and asking to be connected to the Female Health Company
Conference Call, a few minutes before 11:00 a.m. EDT on August 12, 2008. A
replay of the call will be available one hour after the call through 5:00 pm
on August 26, 2008 by dialing 877-344-7529 (international callers dial
412-317-0088) and entering the conference ID 422069.
About The Female Health Company
The Female Health Company (FHC), headquartered in Chicago, IL, is the
maker of the FC Female Condom (FC1 and FC2), a revolutionary option offering
women dual protection against both sexually transmitted diseases, including
HIV/AIDS, and unintended pregnancy. FHC was created as a worldwide company in
February 1996 with the purchase of Chartex Resources Ltd., the holder of
exclusive worldwide rights to FC1. The Company holds exclusive product and
technology patents for FC1 in the United States, Australia, Brazil, Canada,
France, Germany, Italy, Spain, the United Kingdom, the People's Republic of
China, South Korea and Japan. Patents are pending for FC2. FHC is the sole
manufacturer and marketer of the FC1 and FC2 female condoms in the world. The
Female Health Company and its partners currently market the Female Condom
under FC Female Condom(R), FC2 Female Condom(R), Reality(R), Femidom(R),
Femy(R), and Care(R) in the rest of the world.
"Safe Harbor" statement under the Private Securities Litigation Reform
Action of 1995: The statements in this release which are not historical fact
are forward-looking statements based upon the Company's current plans and
strategies, and reflect the Company's current assessment of the risks and
uncertainties related to its business, including such things as product demand
and market acceptance; the economic and business environment and the impact of
government pressures; currency risks; capacity; efficiency and supply
constraints; and other risks detailed in the Company's press releases,
shareholder communications and Securities and Exchange Commission filings.
Actual events affecting the Company and the impact of such events on the
Company's operations may vary from those currently anticipated.
For more information about the Female Health Company visit the Company's web
site at http://www.femalehealth.com and http://www.femalecondom.org.
If you would like to be added to an e-mail alert list, please send an e-mail
to FHCInvestor@femalehealthcompany.com

Contacts: William R. Gargiulo, Jr. 231-526-1244
Donna Felch, CFO 312-595-9123

SOURCE The Female Health Company

William R. Gargiulo, Jr., +1-231-526-1244, or Donna Felch, CFO,
+1-312-595-9123, both of The Female Health Company